LIPOBLASTOMA

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting LIPOBLASTOMA:

# Drug Count
0 DOXORUBICIN 2
1 MITOMYCIN 2
2 NINTEDANIB 2
3 PALBOCICLIB 2
4 PAZOPANIB 2
5 PAZOPANIB HYDROCHLORIDE 2
See all common drugs associated with LIPOBLASTOMA

LIPOBLASTOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MITOMYCIN 2 0.0005
1 PAZOPANIB HYDROCHLORIDE 2 0.0001
2 NINTEDANIB 2 0.0001
3 DOXORUBICIN 2 0.0000
4 PALBOCICLIB 2 0.0000
See all drugs enriched for association with LIPOBLASTOMA

These drug classes are most commonly taken by patients reporting LIPOBLASTOMA:

# Drug class Count
0 Alkylating Drug [EPC] 2
1 Kinase Inhibitor [EPC] 2
See all common drug classes associated with LIPOBLASTOMA

LIPOBLASTOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 2 0.0000
1 Kinase Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with LIPOBLASTOMA